Literature DB >> 35275358

Prognostic value of histopathological scoring and grading in patients with renal AA amyloidosis.

Arzu Ozdemir1, Mürvet Yılmaz2, Ayse Aysim Ozagari3, Sibel Yucel Kocak2.   

Abstract

OBJECTIVE: The amount and distribution pattern of amyloid deposits may contribute to renal function and outcome, given the great diversity of renal involvement in amyloidosis. The aim of this study was to analyze the impact of histological characteristics of patients with biopsy-proven renal AA amyloidosis (AAA) on renal outcome.
METHODS: Renal biopsies of 37 patients with AAA were re-evaluated. The distribution pattern of glomerular amyloid (GA) deposits was classified, the extent of amyloid deposits in glomeruli, vessel, and interstitium and other histopathologic lesions were scored, and renal amyloid prognostic score (RAPS) was determined by summing all scores. Their potential prognostic relevance on renal outcome was investigated.
RESULTS: GA and vascular amyloid (VA) deposits were noted in all cases, interstitial amyloid (IA) was detected in 70.2%. GA deposits were predominantly seen in diffuse mesengiocapillary fashions (class IV) (51.4%). GA class, the extent of GA, VA, IA deposit, and RAPS, as well as interstitial fibrosis (IF) and interstitial inflammation were correlated to renal function at diagnosis. During the median follow-up of 52 months, 13 patients developed doubling of serum creatinine or end stage renal disease and they had a higher degree of GA and VA load (p = 0.03 and p = 0.042, respectively) as compared to the remaining patients. VA load, but not GA and RAPS grade, was associated with poor renal outcome (HR 3.016, 95% CI 1.45-6.25, p = 0.003).
CONCLUSIONS: Baseline renal function is closely linked to the extent of AA amyloid deposit in renal parenchyma but only VA load was a predictor of renal outcome in AAA patients.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  AA amyloidosis; Classification; Renal outcome; Scoring and grading

Mesh:

Substances:

Year:  2022        PMID: 35275358     DOI: 10.1007/s11255-022-03163-y

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.266


  20 in total

Review 1.  Amyloidosis-associated kidney disease.

Authors:  Laura M Dember
Journal:  J Am Soc Nephrol       Date:  2006-11-08       Impact factor: 10.121

2.  Clinical and histological characteristics of renal AA amyloidosis: a retrospective study of 68 cases with a special interest to amyloid-associated inflammatory response.

Authors:  Jérôme Verine; Nathalie Mourad; Kristell Desseaux; Philippe Vanhille; Laure-Hélène Noël; Hélène Beaufils; Gilles Grateau; Anne Janin; Dominique Droz
Journal:  Hum Pathol       Date:  2007-08-21       Impact factor: 3.466

3.  AA amyloid nephropathy with predominant vascular deposition in Crohn's disease.

Authors:  Noriaki Kurita; Nagaaki Kotera; Yu Ishimoto; Mototsugu Tanaka; Shinji Tanaka; Nobuo Toda; Akiko Fujii; Kiyonori Kobayashi; Tokuichiro Sugimoto; Naobumi Mise
Journal:  Clin Nephrol       Date:  2013-03       Impact factor: 0.975

4.  A proposed histopathologic classification, scoring, and grading system for renal amyloidosis: standardization of renal amyloid biopsy report.

Authors:  Sait Sen; Banu Sarsik
Journal:  Arch Pathol Lab Med       Date:  2010-04       Impact factor: 5.534

5.  Two distinct clinical courses of renal involvement in rheumatoid patients with AA amyloidosis.

Authors:  Hiroshi Uda; Akira Yokota; Kumiko Kobayashi; Tadao Miyake; Hiroaki Fushimi; Akira Maeda; Osamu Saiki
Journal:  J Rheumatol       Date:  2006-08       Impact factor: 4.666

6.  Renal involvement in AA amyloidosis: clinical outcomes and survival.

Authors:  Murvet Yilmaz; Abdulkadir Unsal; Mehmet Sokmen; Ozlem Harmankaya Kaptanogullari; Canan Alkim; Fevziye Kabukcuoglu; Aysim Ozagari; Emire Bor
Journal:  Kidney Blood Press Res       Date:  2013-03-12       Impact factor: 2.687

7.  Presentation, survival and prognostic markers in AA amyloidosis.

Authors:  N Joss; K McLaughlin; K Simpson; J M Boulton-Jones
Journal:  QJM       Date:  2000-08

8.  Prognosis of renal amyloidosis: a clinicopathological study using cluster analysis.

Authors:  Y Sasatomi; Y Kiyoshi; N Uesugi; S Hisano; S Takebayashi
Journal:  Nephron       Date:  2001-01       Impact factor: 2.847

9.  Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases.

Authors:  Samar M Said; Sanjeev Sethi; Anthony M Valeri; Nelson Leung; Lynn D Cornell; Mary E Fidler; Loren Herrera Hernandez; Julie A Vrana; Jason D Theis; Patrick S Quint; Ahmet Dogan; Samih H Nasr
Journal:  Clin J Am Soc Nephrol       Date:  2013-05-23       Impact factor: 8.237

Review 10.  New advances in renal amyloidosis.

Authors:  Shinichi Nishi; Bassam Alchi; Nofumi Imai; Fumitake Gejyo
Journal:  Clin Exp Nephrol       Date:  2008-01-05       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.